Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
Other Sizes |
|
Purity: ≥98%
Harringtonine is a natural Cephalotaxus alkaloid found in Cephalotaxuts. It immobilizes initiated ribtosomes, inhibiting protein translation by blocking the ribosomal A site. It suppresses viral replication and protein expression in chikungunya virus infection, inhibits cell growth in actue promyelocytic leukemia cells, and induces apoptosis in leukemia cells.
ln Vitro |
By blocking substrate binding to the acceptor site on the 60-S ribosome subunit, harringtonine inhibits the elongation phase of translation by preventing aminoacyl-tRNA binding and the formation of peptide bonds[1]. With an EC50 of 0.24 μM, harringtonine exhibits strong inhibition of Chikungunya virus infection. Other alphaviruses may be inhibited by harringtonine[2]. At low concentrations, haltrine inhibits the growth of human myeloid leukemia cells in vitro. The breakdown of polysomes into monosomes is thought to be the hallmark of harringtonine's antitumor action mechanism, which is thought to be based on an impact on protein synthesis[3].
|
---|---|
References |
|
Molecular Formula |
C28H37NO9
|
---|---|
Molecular Weight |
531.5947
|
Exact Mass |
531.25
|
Elemental Analysis |
C, 63.26; H, 7.02; N, 2.63; O, 27.09
|
CAS # |
26833-85-2
|
Appearance |
Solid powder
|
SMILES |
O=C(O[C@@H]1C(OC)=C[C@]2(CCC3)N3CCC4=CC5=C(OCO5)C=C4[C@@]21[H])[C@](CCC(C)(O)C)(O)CC(OC)=O
|
InChi Key |
HAVJATCHLFRDHY-KSZYUSJVSA-N
|
InChi Code |
InChI=1S/C28H37NO9/c1-26(2,32)8-9-28(33,15-22(30)35-4)25(31)38-24-21(34-3)14-27-7-5-10-29(27)11-6-17-12-19-20(37-16-36-19)13-18(17)23(24)27/h12-14,23-24,32-33H,5-11,15-16H2,1-4H3/t23-,24-,27+,28-/m1/s1
|
Chemical Name |
1-((1S,3aR,14bS)-2-methoxy-1,5,6,8,9,14b-hexahydro-4H-[1,3]dioxolo[4',5'
|
Synonyms |
2'R-Harringtonine; Harringtonine; Alkaloid C from cephalotaxus; NSC 124147; NSC-124147; NSC124147.
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : ~100 mg/mL ( ~188.11 mM )
Ethanol : ~100 mg/mL |
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (4.70 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (4.70 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (4.70 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. Solubility in Formulation 4: 10% DMSO+40% PEG300+5% Tween-80+45% Saline: ≥ 2.5 mg/mL (4.70 mM) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 1.8811 mL | 9.4057 mL | 18.8115 mL | |
5 mM | 0.3762 mL | 1.8811 mL | 3.7623 mL | |
10 mM | 0.1881 mL | 0.9406 mL | 1.8811 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Dose-dependent inhibition of ribavirin on CHIKV infectivity shown using immunofluorescence assay. [2].Antimicrob Agents Chemother. 2013 Jan;57(1):155-67. td> |
Dose-dependent study of anti-CHIKV activities of selected compounds from a primary high-throughput screen as observed via plaque assay. [2].Antimicrob Agents Chemother. 2013 Jan;57(1):155-67. td> |
Dose-dependent studies of antiviral activities of harringtonine and homoharringtonine against both CHIKV strains.[2].Antimicrob Agents Chemother. 2013 Jan;57(1):155-67. td> |
Antiviral effect of harringtonine on CHIKV infection of HSMM (primary human skeletal myoblasts), an in vivo target of CHIKV infection. [2].Antimicrob Agents Chemother. 2013 Jan;57(1):155-67. td> |
(a) BHK21 cells were treated with harringtonine at different time points before and after infection in time-of addition studies. [2].Antimicrob Agents Chemother. 2013 Jan;57(1):155-67. td> |
Western blot analyses were performed to determine the effect of harringtonine on production of CHIKV nsP3 and E2 proteins. [2].Antimicrob Agents Chemother. 2013 Jan;57(1):155-67. td> |